TCF vs. SOS, VEL, HARL, ING, SPO, IX, NWT, TREE, STL, and HWC
Should you be buying Theracryf stock or one of its competitors? The main competitors of Theracryf include Sosandar (SOS), Velocity Composites (VEL), Harland & Wolff Group (HARL), Ingenta (ING), Sportech (SPO), i(x) Net Zero (IX), Newmark Security (NWT), Cambium Global Timberland (TREE), Stilo International (STL), and Highway Capital (HWC). These companies are all part of the "banking" industry.
Theracryf vs.
Sosandar (LON:SOS) and Theracryf (LON:TCF) are both small-cap consumer cyclical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, valuation, earnings, profitability, media sentiment and community ranking.
Sosandar has higher revenue and earnings than Theracryf. Sosandar is trading at a lower price-to-earnings ratio than Theracryf, indicating that it is currently the more affordable of the two stocks.
Sosandar has a net margin of -0.91% compared to Theracryf's net margin of -792.17%. Sosandar's return on equity of -2.39% beat Theracryf's return on equity.
Sosandar has a beta of 2.28, meaning that its stock price is 128% more volatile than the S&P 500. Comparatively, Theracryf has a beta of 1.42, meaning that its stock price is 42% more volatile than the S&P 500.
60.2% of Sosandar shares are owned by institutional investors. Comparatively, 37.0% of Theracryf shares are owned by institutional investors. 31.2% of Sosandar shares are owned by insiders. Comparatively, 42.9% of Theracryf shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
In the previous week, Sosandar had 1 more articles in the media than Theracryf. MarketBeat recorded 1 mentions for Sosandar and 0 mentions for Theracryf. Sosandar's average media sentiment score of 0.00 equaled Theracryf'saverage media sentiment score.
Sosandar received 123 more outperform votes than Theracryf when rated by MarketBeat users.
Summary
Sosandar beats Theracryf on 10 of the 13 factors compared between the two stocks.
Get Theracryf News Delivered to You Automatically
Sign up to receive the latest news and ratings for TCF and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Theracryf Competitors List
Related Companies and Tools
This page (LON:TCF) was last updated on 2/22/2025 by MarketBeat.com Staff
Free TCF Stock Alerts